Pharmacokinetics & Metabolism

Bioavailability

Standard oral curcumin has poor bioavailability.

Main reasons:

• poor water solubility

• rapid metabolism

• rapid elimination

• intestinal and hepatic conjugation

Enhanced-delivery systems such as liposomal, micellar, phospholipid, or nanoparticle formulations are often much more clinically relevant than plain powder.

Enhancement strategies

1. Liposomal delivery — improves absorption and circulation time

2. Piperine co-administration — can greatly increase standard curcumin absorption

3. Phospholipid complexes — improve dissolution and uptake

4. Nanoparticle systems — may improve gastrointestinal absorption and tissue delivery

CYP metabolism and interaction considerations

Curcumin has interaction relevance through CYP enzymes and transporters.

Commonly discussed pathways:

• CYP3A4

• CYP2C9

• CYP1A2

• P-glycoprotein

• BCRP

Why this matters: many oncology drugs rely on these systems for metabolism or transport.

For a treatment-specific example, see Natural Compounds and CYP3A4 — HER2CLIMB Considerations.

Oncology drug classes that may be relevant

• taxanes

• vinca alkaloids

• tyrosine kinase inhibitors

• CDK4/6 inhibitors

• mTOR inhibitors

• corticosteroids

• opioids

• some antiemetics

Protein binding and half-life

• High protein binding is expected

• Free curcumin has a short plasma half-life

• Metabolites persist longer than free curcumin

• Tissue retention can outlast plasma detection

Clearance and metabolites

• Primarily hepatic metabolism with biliary excretion

• Secondary renal excretion of metabolites

• Major metabolites include glucuronide and sulphate conjugates, plus tetrahydrocurcumin

Blood-brain barrier relevance

Standard formulations appear to have limited CNS penetration. Enhanced formulations may improve this, which is one reason curcumin remains of interest in brain tumour research.

Interaction checkers

• Memorial Sloan Kettering — About Herbs Database
  https://www.mskcc.org/cancer-care/diagnosis-treatment/symptom-management/integrative-medicine/herbs

• Drugs.com Interaction Checker
  https://www.drugs.com/drug_interactions.html

References

Bioavailability of Curcumin: Problems and Promises
https://pubmed.ncbi.nlm.nih.gov/30590123/

Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers
https://pubmed.ncbi.nlm.nih.gov/9619120/

Inhibition of human cytochrome P450 enzymes by curcumin and curcumin decomposition products
https://pubmed.ncbi.nlm.nih.gov/17433521/

Oral bioavailability of curcumin: problems and advances in P-glycoprotein and CYP3A modulation research
https://pubmed.ncbi.nlm.nih.gov/17050652/

Improving Curcumin Bioavailability: Current Strategies and Future Perspectives
https://pmc.ncbi.nlm.nih.gov/articles/PMC8540263/

Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?
https://pubs.acs.org/doi/10.1021/acsomega.2c07326